Copyright
©The Author(s) 2015.
World J Gastroenterol. May 14, 2015; 21(18): 5568-5574
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5568
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5568
Figure 1 Flow schematic of the study included in intention-to-treat and per-protocol analyses.
ITT: Intention-to-treat; PP: Per-protocol; RAM-7: Rabeprazole/amoxicillin/moxifloxacin triple therapy x 7 d; RAM-14: Rabeprazole/amoxicillin/moxifloxacin triple therapy x 14 d.
-
Citation: Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N. Efficacy of 14-d
vs 7-d moxifloxacin-based triple regimens for second-lineHelicobacter pylori eradication. World J Gastroenterol 2015; 21(18): 5568-5574 - URL: https://www.wjgnet.com/1007-9327/full/v21/i18/5568.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i18.5568